4[1]Comillie F,Shealy D,D'Haens G,et al.Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.Aliment Pharmacol Ther,2001,15(4):463～73.
5[2]Kono T,Nomura M,Kasai S,et al.Effect of ecabet sodium enema on mildly no moderately active ulcerative proctosigrnoiditis: an open-label study.Am J Gastroenterol,2001,96(3):793～7.
6[3]Bennink R,Peeters M,D'Haens G,et al.Tc-99m HMPAO white blood call scintigraphy in the assessment of the extent and se verity of an acute exacerbation of ulcerative colitis.Clin Nucl Med,2001,26(2):99～104.
7[4]Bitton A,Peppercorn MA,Antonioli DA,et al.Clinical,biological,and histologic parameters as predictors of relapse in ulcerative colitis.Gastroenterology,2001,120( 1 ): 13～ 20.
8[5]Ierardi E,Principi M,Francavilla R,et al.Oral tacrolimus longterm therapy in patients with Crohn's disease and steroid resistance.Aliment Pharmacol Ther,2001,15(3):371～7.
9[6]Cortot A,Colombel JF,Rutgeerts P,et al.Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.Gut,201,48(2): 186～90.
10[7]Ettorre GM,Peseatofi M,Panis Y,et al.Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn's colitis.Dis Colon Rectum,2000,43(12): 1743 ～8.
